Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4827-4836

  Dumon, Kristoffel R ^a,b   Ishii, Hideshi ^a   Vecchione, Andrea ^a   Trapasso, Francesco ^a   Baldassarre, Gustavo ^a   Chakrani, Fatima ^a   Druck, Teresa ^a   Rosato, Ernest F ^b   Williams, Noel N ^b   Baffa, Raffaele ^a   During, Matthew J ^a   Huebner, Kay ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; DNA FRAGMENT; FRAGILE HISTIDINE TRIAD PROTEIN;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL SURFACE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT;

ACID ANHYDRIDE HYDROLASES; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CASPASES; CELL CYCLE; CELL DIVISION; DNA FRAGMENTATION; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; MITOCHONDRIA; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035874950     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Cancer statistics, 1999
2. Pancreatic carcinoma
3. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients
4. p53 and K-RAS alterations in pancreatic epithelial cell lesions
5. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
6. Gene deletion chemoselectivity: Codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the α- and β-IFNs in human pancreatic cell carcinoma lines and its implications for chemotherapy
7. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers
8. Gene therapy for primary and metastatic pancreatic cancer with I.P. Retroviral vector bearing the wild-type p53 gene
9. Phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma
10. Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus
11. Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene
12. The role of the FHIT/FRA3B locus in cancer
13. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines
14. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vectormediated fragile histidine triad (FHIT) gene overexpression
15. Effect of adenoviral transduction of FHIT into esophageal cancer cells
16. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control
17. In situ gene therapy for adenocarcinoma of the prostate: A Phase I clinical trial
18. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus
19. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA
20. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
21. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector
22. AAV vectors: Is clinical success on the horizon?
23. Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors
24. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
25. Recombinant adeno-associated virus for muscle directed gene therapy
26. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle
27. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene
28. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer
29. Novel tools for production and purification of recombinant adenoassociated virus vectors
30. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
31. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation
32. Protein farnesyltransferase inhibitors block the growth of ras- dependent tumors in nude mice
33. A comprehensive system to explore p53 mutations
34. αVβ5 integrin: A co-receptor for adeno-associated virus type 2 infection
35. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
36. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions
37. Cell receptors involved in adenovirus entry
38. Replacement of Fhit in cancer cells suppresses tumorigenicity
39. Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression
40. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity
41. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
42. Mitochondrion as a novel target of anticancer chemotherapy
43. Mechanisms of apoptosis avoidance in cancer
44. Apoptosis, cancer and cancer therapy
45. Escaping cell death: Survival proteins in cancer
46. The hallmarks of cancer
47. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
48. Deficiency in caspase-9 or caspase-3 induces compensatory, caspase activation
49. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
50. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
51. Cancer gene therapy: Hard lessons and new courses
52. Persistent expression of human clotting factor IX from mouse liver after I.V. Injection of adeno-associated virus vectors
53. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
54. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin